Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study
N. El Ouardi, A. El Maghraoui, H.J. Djossou, L. Taoubane, Mohamed Ahmed Ghassem, Hamza Toufik, A. Majjad, Siham Sadni, Aziza Mounach, Ihsane Hmamouchi, Rédouane Abouqal, R. Bahiri, F. Allali, I. El Bouchti, I. Ghozlani, H. Hassikou, Taoufik Harzy, L. Ichchou, O. Mkinsi, R. Niamane, A. Bezza
Topics & Concepts
MedicineDiscontinuationBASDAIAnkylosing spondylitisInternal medicineRheumatoid arthritisRheumatologyCohortAdverse effectTNF inhibitorTofacitinibEtanerceptPsoriatic arthritisRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsPsoriasis: Treatment and Pathogenesis